Exploring Platelet-Rich Plasma Therapy for Orthopedic Conditions: A Comprehensive Analysis

A Study Evaluating Platelet-Rich Plasma in Orthopedics Disorders

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067049

Enrollment

1250

Registered

2024-05-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified

Interventions

Intervention1: Platelet-rich plasma infiltration: Through Direct or Indirect delivery/application of PRP ( both fluid /gels) under Ultrasound/IITV Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Fractures and its Impairments Wounds & Suturing. Tendinopathies and tendon injuries Bone defects Osteoarthritis Osteomyelitis Regeneration of acute and chronic Ischemia of the Limb including progressive necrosis or Gangrenes

Exclusion criteria

Exclusion criteria: High Risk Patients with low Haemoglobin, bleeding disorders, abnormal haematocrit counts particularly subnormal platelet count

Design outcomes

Primary

Measure	Time frame
To test the long-term Safety and Efficacy of PRP in Orthopaedic Practice, developing it as a therapeutic interventionTimepoint: 10 years	—

Secondary

Measure	Time frame
Complete healing of Orthopaedic disordersTimepoint: 10 years	—

Countries

India

Contacts

Public ContactDr Sandeep Shrivastava

ceohospitals@gmail.com09765404068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026